The role of the emergency department in acute heart failure clinical trials--enriching patient identification and enrollment.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  American Heart Journal

• Publication date

  2013-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ahj.2013.03.009PMID 23708160PMCID PMC3664838
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions

  2014cited by this paper
• Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.

  2013cited by this paper
• Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial.

  2013cited by this paper
• Bayesian adaptive trial design in acute heart failure syndromes: moving beyond the mega trial.

  2012cited by this paper
• Intramuscular versus intravenous therapy for prehospital status epilepticus.

  2012cited by this paper
• Abstract 15606: Clevidipine Improves Dyspnea in Emergency Department Acute Heart Failure: A Randomized, Open Label Study

  2012cited by this paper
• Relationship Between Chest Compression Rates and Outcomes From Cardiac Arrest

  2012cited by this paper
• Effect of Nesiritide in Patients with Acute Decompensated Heart Failure

  2012cited by this paper
• Effects of tolvaptan on physician-assessed symptoms and signs in patients hospitalized with acute heart failure syndromes: analysis from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) trials.

  2011cited by this paper
• Effect of nesiritide in patients with acute decompensated heart failure.

  2011cited by this paper
• A trial of an impedance threshold device in out-of-hospital cardiac arrest.

  2011cited by this paper
• Clinical Trials of Pharmacological Therapies in Acute Heart Failure Syndromes: Lessons Learned and Directions Forward

  2010cited by this paper
• Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association.

  2010cited by this paper
• The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study.

  2010cited by this paper
• HFSA 2010 Comprehensive Heart Failure Practice Guideline.

  2010cited by this paper
• National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities.

  2010cited by this paper
• Early vasoactive drugs improve heart failure outcomes.

  2009cited by this paper
• Identification of children at very low risk of clinically-important brain injuries after head trauma: a prospective cohort study.

  2009cited by this paper
• Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study.

  2009cited by this paper
• Effects of tolvaptan on dyspnoea relief from the EVEREST trials.

  2009cited by this paper
• Day of Admission and Clinical Outcomes for Patients Hospitalized for Heart FailureCLINICAL PERSPECTIVE

  2008cited by this paper
• Who is managing acute decompensated heart failure? The need for a multidisciplinary approach.

  2008cited by this paper
• Comparison of practice patterns of hospitalists and community physicians in the care of patients with congestive heart failure.

  2008cited by this paper
• Beyond pulmonary edema: diagnostic, risk stratification, and treatment challenges of acute heart failure management in the emergency department.

  2008cited by this paper
• Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.

  2008cited by this paper
• Day of Admission and Clinical Outcomes for Patients Hospitalized for Heart Failure: Findings From the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF)

  2008cited by this paper
• Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.

  2007cited by this paper
• A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis.

  2007cited by this paper
• Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.

  2006cited by this paper
• Impact of Early Initiation of Intravenous Therapy for Acute Decompensated Heart Failure on Outcomes in ADHERE

  2006cited by this paper
• Ultrasound lung comets: a clinically useful sign of extravascular lung water.

  2006cited by this paper
• Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure.

  2006cited by this paper
• Does this dyspneic patient in the emergency department have congestive heart failure?

  2005cited by this paper
• Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial.

  2004cited by this paper
• The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure.

  2003cited by this paper

• Disposition of acute decompensated heart failure from the emergency department: An evidence-based review.

  2021cites this paper
• Identificación y prevalencia de factores precipitantes de insuficiencia cardiaca aguda en los servicios de urgencias españoles y su relación con el pronóstico a corto y medio plazo

  2018cites this paper
• Presenting phenotypes of acute heart failure patients in the ED: Identification and implications

  2017cites this paper
• Relaxin: A Novel Agent for the Treatment of Acute Heart Failure

  2015cites this paper
• How does a clinical trial fit into the real world? The RELAX-AHF study population into the EAHFE registry

  2015cites this paper
• Características clínicas, terapéuticas y evolutivas de los pacientes con insuficiencia cardiaca aguda atendidos en servicios de urgencias españoles: Registro EAHFE (Epidemiology of Acute Heart Failure in Spanish Emergency Departments)

  2015cites this paper
• Identifying Barriers and Practical Solutions to Conducting Site-Based Research in North America: Exploring Acute Heart Failure Trials As a Case Study.

  2015cites this paper
• [Characteristics and clinical course of patients with acute heart failure and the therapeutic measures applied in Spanish emergency departments: based on the EAHFE registry (Epidemiology of Acute Heart Failure in Emergency Departments)].

  2015cites this paper
• Physicians’ Perception of the Patient Care Pathway for Acute Heart Failure in Asian Countries: Implications for Resource Allocation, Preventive Strategies and Clinical Trial Design

  2014cites this paper
• Comments on "the role of the emergency department in acute heart failure clinical trials-Enriching patient identification and enrollment" by Collins et al.

  2013cites this paper
• BARRIER: POOR VISIBILITY OF CARDIOVASCULAR DISEASE AND CLINICAL TRIALS WITHIN THE INSTITUTION AND THE BROADER COMMUNITY

  year unknowncites this paper